CAN FITE BIO (CANF)
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
Avalo Therapeutics to Join the Russell2000® and Russell 3000® Indexes
Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
Baker Hughes Announces Dates for Second-Quarter Earnings Release and Webcast
VENU CEO J.W. Roth Featured on The Business Digest Radio Show & Podcast
Tilray Medical Expands Medical Cannabis Access for Veterans Through Lyphe Clinic at Aldershot’s Armed Forces Weekend
Aurora Mobile’s JPush Empowers Yuanda Information’s Caiyuan Gungun App with Millisecond-Level, Precise User Engagement